Skip to content

Kenvue KVUE Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Colgate-Palmolive logo
Colgate-PalmoliveCL
Kimberly-Clark logo
Kimberly-ClarkKMB
Clorox logo
CloroxCLX
PBH
Prestige Consumer HealthcarePBH
Edgewell Personal Care logo
Edgewell Personal CareEPC
Helen Of Troy logo
Helen Of TroyHELE

Other financials

Income statement

See full
Revenue$3.9B+4.5%
Gross profit$2.3B+6.2%
Operating income$767.0M+37.5%
Net income$474.0M+47.2%
EPS (diluted)$0.25+47.1%

Balance sheet

See full
Cash & equivalents$1.1B+1.7%
Total debt$8.8B-8.3%
Total equity$10.6B+5.5%
Total assets$26.9B+2.3%

Cash flow

See full
Operating cash flow$489.0M+14.3%
CapEx$139.0M-22.3%
Free cash flow$350.0M+40.6%

Valuation

See full
Market cap$36.69B-6.1%
Enterprise value$44.42B-6.4%
P/E22.6×-4.9×
P/S2.4×-0.2×

Profitability

See full
Gross margin58.4%+0.3pp
Operating margin17.2%+5.1pp
Net margin10.6%+3.7pp
FCF margin11.9%+2.4pp

Returns & leverage

See full
Return on equity15.7%+5.5pp
Debt / equity0.8×-0.1×
Current ratio+0.1×

Where this comes from

Reported directly by Kenvue in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Kenvue’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kenvue's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kenvue's common stock, shares authorized (in shares)?
Kenvue (KVUE) reported common stock, shares authorized (in shares) of $12.5B in Q1 2026.
How has Kenvue's common stock, shares authorized (in shares) changed year-over-year?
Kenvue's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $12.5B to $12.5B.
What is the long-term trend for Kenvue's common stock, shares authorized (in shares)?
Over 3 years (2022 to 2025), Kenvue's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $12.5B to $12.5B.